
Andalib Ft Lodhi
Examiner (ID: 12467, Phone: (571)270-1759 , Office: P/2162 )
| Most Active Art Unit | 2162 |
| Art Unit(s) | 2163, 2169, 2154, 2162 |
| Total Applications | 390 |
| Issued Applications | 276 |
| Pending Applications | 2 |
| Abandoned Applications | 112 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 18162088
[patent_doc_number] => 20230028680
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-01-26
[patent_title] => EXPANSION OF NATURAL KILLER CELLS AND ILC3 CELLS WITH NOVEL AROMATIC COMPOUNDS
[patent_app_type] => utility
[patent_app_number] => 17/309449
[patent_app_country] => US
[patent_app_date] => 2019-11-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 75844
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17309449
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/309449 | EXPANSION OF NATURAL KILLER CELLS AND ILC3 CELLS WITH NOVEL AROMATIC COMPOUNDS | Nov 28, 2019 | Abandoned |
Array
(
[id] => 17367395
[patent_doc_number] => 20220022447
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-01-27
[patent_title] => EX VIVO ORGAN TREATMENT WITH PEG-PHOSPHOLIPID MOLECULES
[patent_app_type] => utility
[patent_app_number] => 17/297112
[patent_app_country] => US
[patent_app_date] => 2019-11-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 16012
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -27
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17297112
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/297112 | EX VIVO ORGAN TREATMENT WITH PEG-PHOSPHOLIPID MOLECULES | Nov 28, 2019 | Pending |
Array
(
[id] => 17314821
[patent_doc_number] => 20210403869
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-12-30
[patent_title] => Osteoblasts derived from oral neuroectodermal stem cells and their use in jaw repair
[patent_app_type] => utility
[patent_app_number] => 17/291661
[patent_app_country] => US
[patent_app_date] => 2019-11-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 3856
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -12
[patent_words_short_claim] => 37
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17291661
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/291661 | Osteoblasts derived from oral neuroectodermal stem cells and their use in jaw repair | Nov 27, 2019 | Abandoned |
Array
(
[id] => 17383906
[patent_doc_number] => 20220031758
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-02-03
[patent_title] => USE OF ANIMAL ORIGINATED CORNEA MEMBRANE PRODUCTS IN TREATMENT OF EYE AND OUT OF EYE WOUNDS
[patent_app_type] => utility
[patent_app_number] => 17/298784
[patent_app_country] => US
[patent_app_date] => 2019-11-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 2139
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -7
[patent_words_short_claim] => 15
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17298784
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/298784 | USE OF ANIMAL ORIGINATED CORNEA MEMBRANE PRODUCTS IN TREATMENT OF EYE AND OUT OF EYE WOUNDS | Nov 27, 2019 | Abandoned |
Array
(
[id] => 17299837
[patent_doc_number] => 20210395676
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-12-23
[patent_title] => CARRIER FOR CELL CULTURE COMPRISING MICROCAPSULES CONTAINING NATURAL OIL
[patent_app_type] => utility
[patent_app_number] => 17/283503
[patent_app_country] => US
[patent_app_date] => 2019-11-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 6787
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -9
[patent_words_short_claim] => 20
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17283503
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/283503 | CARRIER FOR CELL CULTURE COMPRISING MICROCAPSULES CONTAINING NATURAL OIL | Nov 11, 2019 | Pending |
Array
(
[id] => 17370284
[patent_doc_number] => 20220025336
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-01-27
[patent_title] => METHOD FOR PRODUCING INSULIN-PRODUCING CELLS, AND COMPOSITION
[patent_app_type] => utility
[patent_app_number] => 17/288636
[patent_app_country] => US
[patent_app_date] => 2019-11-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 6766
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -16
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17288636
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/288636 | METHOD FOR PRODUCING INSULIN-PRODUCING CELLS, AND COMPOSITION | Nov 10, 2019 | Pending |
Array
(
[id] => 17299823
[patent_doc_number] => 20210395662
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-12-23
[patent_title] => Cell Culture Device
[patent_app_type] => utility
[patent_app_number] => 17/292245
[patent_app_country] => US
[patent_app_date] => 2019-11-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 5501
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -5
[patent_words_short_claim] => 21
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17292245
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/292245 | Cell Culture Device | Nov 7, 2019 | Pending |
Array
(
[id] => 17256802
[patent_doc_number] => 20210369787
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-12-02
[patent_title] => ADIPOCYTE MEDIATED DELIVERY OF ANTICANCER THERAPEUTICS
[patent_app_type] => utility
[patent_app_number] => 17/290470
[patent_app_country] => US
[patent_app_date] => 2019-11-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 16541
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -6
[patent_words_short_claim] => 13
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17290470
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/290470 | ADIPOCYTE MEDIATED DELIVERY OF ANTICANCER THERAPEUTICS | Oct 31, 2019 | Abandoned |
Array
(
[id] => 17273047
[patent_doc_number] => 20210379245
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-12-09
[patent_title] => Soluble Extracellular Matrix Composition and Method for Intravascular Delivery
[patent_app_type] => utility
[patent_app_number] => 17/286534
[patent_app_country] => US
[patent_app_date] => 2019-10-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 8650
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -28
[patent_words_short_claim] => 35
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17286534
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/286534 | Soluble Extracellular Matrix Composition and Method for Intravascular Delivery | Oct 24, 2019 | Pending |
Array
(
[id] => 15527687
[patent_doc_number] => 20200056149
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-02-20
[patent_title] => READY-TO-USE CRYOPRESERVED CELLS
[patent_app_type] => utility
[patent_app_number] => 16/664182
[patent_app_country] => US
[patent_app_date] => 2019-10-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 14207
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -15
[patent_words_short_claim] => 30
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16664182
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/664182 | READY-TO-USE CRYOPRESERVED CELLS | Oct 24, 2019 | Pending |
Array
(
[id] => 17214782
[patent_doc_number] => 20210348119
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-11-11
[patent_title] => COMPOSITIONS AND METHODS FOR CELL CULTURE
[patent_app_type] => utility
[patent_app_number] => 17/284215
[patent_app_country] => US
[patent_app_date] => 2019-10-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 21625
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17284215
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/284215 | COMPOSITIONS AND METHODS FOR CELL CULTURE | Oct 10, 2019 | Pending |
Array
(
[id] => 17198799
[patent_doc_number] => 20210338893
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-11-04
[patent_title] => BIOLOGIC TISSUE PROCESSING DEVICE
[patent_app_type] => utility
[patent_app_number] => 17/283263
[patent_app_country] => US
[patent_app_date] => 2019-10-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 10170
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17283263
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/283263 | BIOLOGIC TISSUE PROCESSING DEVICE | Oct 9, 2019 | Abandoned |
Array
(
[id] => 17385924
[patent_doc_number] => 20220033776
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-02-03
[patent_title] => METHODS OF MAKING PLATELETS COMPRISING MODIFIED RECEPTORS AND USES THEREOF
[patent_app_type] => utility
[patent_app_number] => 17/280415
[patent_app_country] => US
[patent_app_date] => 2019-10-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 17803
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17280415
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/280415 | METHODS OF MAKING PLATELETS COMPRISING MODIFIED RECEPTORS AND USES THEREOF | Sep 30, 2019 | Pending |
Array
(
[id] => 17299842
[patent_doc_number] => 20210395681
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-12-23
[patent_title] => CULTURE MEDIUM FOR GROWTH OF NEURAL STEM CELLS
[patent_app_type] => utility
[patent_app_number] => 17/283955
[patent_app_country] => US
[patent_app_date] => 2019-09-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 4795
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -11
[patent_words_short_claim] => 20
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17283955
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/283955 | CULTURE MEDIUM FOR GROWTH OF NEURAL STEM CELLS | Sep 26, 2019 | Abandoned |
Array
(
[id] => 17315913
[patent_doc_number] => 20210404961
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-12-30
[patent_title] => METHODS AND USES FOR DETERMINING OSTEOGENIC POTENTIAL OF IN VITRO DIFFERENTIATED CELLS
[patent_app_type] => utility
[patent_app_number] => 17/279294
[patent_app_country] => US
[patent_app_date] => 2019-09-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 33747
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17279294
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/279294 | METHODS AND USES FOR DETERMINING OSTEOGENIC POTENTIAL OF IN VITRO DIFFERENTIATED CELLS | Sep 24, 2019 | Abandoned |
Array
(
[id] => 17299847
[patent_doc_number] => 20210395686
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-12-23
[patent_title] => METHODS FOR DIFFERENTIATING MESENCHYMAL STEM CELLS
[patent_app_type] => utility
[patent_app_number] => 17/278938
[patent_app_country] => US
[patent_app_date] => 2019-09-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 30260
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 66
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17278938
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/278938 | METHODS FOR DIFFERENTIATING MESENCHYMAL STEM CELLS | Sep 24, 2019 | Abandoned |
Array
(
[id] => 17228615
[patent_doc_number] => 20210355171
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-11-18
[patent_title] => ADENO-ASSOCIATED VIRUS HAVING A VARIANT CAPSID PROTEIN, AND USE THEREOF
[patent_app_type] => utility
[patent_app_number] => 17/284673
[patent_app_country] => US
[patent_app_date] => 2019-09-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 6091
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -19
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17284673
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/284673 | ADENO-ASSOCIATED VIRUS HAVING A VARIANT CAPSID PROTEIN, AND USE THEREOF | Sep 23, 2019 | Pending |
Array
(
[id] => 17426033
[patent_doc_number] => 20220053741
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-02-24
[patent_title] => Complement Factor H Gene Knockout Rat as a Model of C3 Glomerulopathy
[patent_app_type] => utility
[patent_app_number] => 17/275096
[patent_app_country] => US
[patent_app_date] => 2019-09-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 29431
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -53
[patent_words_short_claim] => 11
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17275096
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/275096 | Complement factor H gene knockout rat as a model of C3 glomerulopathy | Sep 11, 2019 | Issued |
Array
(
[id] => 16948397
[patent_doc_number] => 20210207088
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-07-08
[patent_title] => COMPOSITION AND METHOD FOR PRESERVING OR CULTURING OCULAR CELLS
[patent_app_type] => utility
[patent_app_number] => 17/269278
[patent_app_country] => US
[patent_app_date] => 2019-08-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 13866
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -19
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17269278
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/269278 | COMPOSITION AND METHOD FOR PRESERVING OR CULTURING OCULAR CELLS | Aug 29, 2019 | Abandoned |
Array
(
[id] => 17154148
[patent_doc_number] => 20210315199
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-10-14
[patent_title] => CRYOPRESERVATION MEDIUM FOR UMBILICAL CORD MSCS DERIVED FROM WHARTON'S JELLY
[patent_app_type] => utility
[patent_app_number] => 17/267545
[patent_app_country] => US
[patent_app_date] => 2019-08-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 3260
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17267545
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/267545 | CRYOPRESERVATION MEDIUM FOR UMBILICAL CORD MSCS DERIVED FROM WHARTON'S JELLY | Aug 11, 2019 | Abandoned |